Home › NDC Lookup › RxCUI directory › RxCUI 994528

Aspirin 385 MG / caffeine 30 MG / orphenadrine citrate 25 MG Oral Tablet — RxCUI 994528

Name: Aspirin 385 MG / caffeine 30 MG / orphenadrine citrate 25 MG Oral Tablet (RxCUI 994528)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 994528 Semantic clinical drug · SCD ● Current RxNorm concept 2 FDA products 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI994528

Official nameAspirin 385 MG / caffeine 30 MG / orphenadrine citrate 25 MG Oral Tablet

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

Also known asASA 385 MG / Caffeine 30 MG / Orphenadrine Citrate 25 MG Oral Tablet

FDA products mapped2

Package NDCs mapped2

Reported Medicaid activity (SDUD)2,687 prescriptions · 7 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Aspirin Rectal: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Great question. A rectal suppository gets the medication into your system through the lining of the rectum rather than your stomach. This can be helpful if you're having trouble sw...
Why would someone use a rectal suppository instead of just taking aspirin by mouth?
First, check that the foil or plastic packet is fully sealed and undamaged before you open it — don't use it if it looks like it's already been opened. Once you open it, insert the...
This is really important: aspirin — including the suppository form — should NOT be given to children or teenagers who have or are recovering from chicken pox or the flu. There is a...

📖 Read our full Aspirin Rectal guide →

🕸️ Concept Web — How Aspirin 385 MG / caffeine 30 MG / orphenadrine c... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Aspirin 385 MG / caffeine 30 MG / orphenadrine citrate 25 MG Oral Tablet RxCUI 994528 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 5

The active substance itself — no strength, form, or brand attached yet.
- Aspirin 1191 IN
- Caffeine 1886 IN
- Orphenadrine 7715 IN
- Aspirin / caffeine / orphenadrine 466549 MIN
- Orphenadrine citrate 7716 PIN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Norgesic 218776 BN
Dose forms 13

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Aspirin / caffeine / orphenadrine Oral Tablet 374758 SCDF
- Aspirin / caffeine / orphenadrine citrate Oral Tablet 2645484 SCDFP
- Aspirin / caffeine / orphenadrine Oral Product 1153231 SCDG
- Aspirin / caffeine / orphenadrine Pill 1153232 SCDG
- Aspirin / caffeine / orphenadrine citrate Oral Product 2661484 SCDGP
- Aspirin / caffeine / orphenadrine citrate Pill 2660979 SCDGP
- Aspirin / caffeine / orphenadrine Oral Tablet [Norgesic] 367717 SBDF
- Aspirin / caffeine / orphenadrine citrate Oral Tablet [Norgesic] 2654521 SBDFP
- +5 more in this family
Clinical & branded drugs 5

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Aspirin 385 MG 336010 SCDC
- Caffeine 30 MG 315509 SCDC
- Orphenadrine citrate 25 MG 994527 SCDC
- Aspirin 385 MG / caffeine 30 MG / orphenadrine citrate 25 MG Oral Tablet [Norgesic] 994530 SBD
- Aspirin 385 MG / caffeine 30 MG / orphenadrine citrate 25 MG [Norgesic] 994529 SBDC

Showing up to 8 concepts per family — 19 of 24 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Aspirin 385 MG SCDC · 336010
Caffeine 30 MG SCDC · 315509
Orphenadrine citrate 25 MG SCDC · 994527
Aspirin / caffeine / orphenadrine Oral Tablet SCDF · 374758
Aspirin / caffeine / orphenadrine citrate Oral Tablet SCDFP · 2645484
Aspirin / caffeine / orphenadrine Oral Product SCDG · 1153231
Aspirin / caffeine / orphenadrine Pill SCDG · 1153232
Aspirin / caffeine / orphenadrine citrate Oral Product SCDGP · 2661484
Aspirin / caffeine / orphenadrine citrate Pill SCDGP · 2660979

Brand-Name Concepts

Aspirin 385 MG / caffeine 30 MG / orphenadrine citrate 25 MG Oral Tablet [Norgesic] SBD · 994530
Aspirin 385 MG / caffeine 30 MG / orphenadrine citrate 25 MG [Norgesic] SBDC · 994529
Aspirin / caffeine / orphenadrine Oral Tablet [Norgesic] SBDF · 367717
Aspirin / caffeine / orphenadrine citrate Oral Tablet [Norgesic] SBDFP · 2654521
Norgesic Oral Product SBDG · 1185684
Norgesic Pill SBDG · 1185685
Norgesic BN · 218776

📦 FDA Products & Package NDCs

2 products · 2 package NDCs

2 package NDCs map to RxCUI 994528 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
61825-0305-60	60 TABLET in 1 BOTTLE, PLASTIC (61825-305-60)	Norgesic	Galt Pharmaceuticals, LLC	2022-05-16
71993-0304-60	60 TABLET in 1 BOTTLE, PLASTIC (71993-304-60)	Orphenadrine Citrate, Aspirin and Caffeine	Atland Pharmaceuticals, LLC	2022-03-18

Observed labelers: Atland Pharmaceuticals, LLC (1) · Galt Pharmaceuticals, LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.